Literature DB >> 8094116

Abnormal growth regulation of vascular smooth muscle cells by heparin in patients with restenosis.

P Chan1, M Patel, L Betteridge, E Munro, M Schachter, J Wolfe, P Sever.   

Abstract

Proliferation of vascular smooth muscle cells (VSMC) underlies myointimal hyperplasia, which can lead to restenosis after angioplasty and vascular surgery. We propose that some individuals have an intrinsic capacity for this exaggerated response to vascular injury, partly through decreased sensitivity to the physiological growth inhibitor heparin. We investigated the effect of heparin on VSMC from restenotic lesions and from apparently normal vessels of the same patients, and VSMC from control patients undergoing primary bypass procedures. Cells from patients with restenosis (both restenotic lesion and undiseased vein) showed much lower sensitivity to growth inhibition by heparin than the controls (median inhibition 8 [95% Cl -2 to 25] vs 22 [15-44]%, p < 0.001); this finding suggests aberrant growth regulation in these cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8094116     DOI: 10.1016/0140-6736(93)90139-8

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  8 in total

1.  Scavenger receptor class A member 5 (SCARA5) and suprabasin (SBSN) are hub genes of coexpression network modules associated with peripheral vein graft patency.

Authors:  Richard D Kenagy; Mete Civelek; Shinsuke Kikuchi; Lihua Chen; Anthony Grieff; Michael Sobel; Aldons J Lusis; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2015-04-30       Impact factor: 4.268

2.  Effect of recombinant growth factors on human saphenous vein smooth muscle cells.

Authors:  P Dunlop; K Porter; K Varty; P Bell; N London
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-06       Impact factor: 2.416

3.  Characterization of [3H]-heparin binding in human vascular smooth muscle cells and its relationship to the inhibition of DNA synthesis.

Authors:  M K Patel; J S Refson; M Schachter; A D Hughes
Journal:  Br J Pharmacol       Date:  1999-05       Impact factor: 8.739

4.  Genomic instability in the type II TGF-beta1 receptor gene in atherosclerotic and restenotic vascular cells.

Authors:  T A McCaffrey; B Du; S Consigli; P Szabo; P J Bray; L Hartner; B B Weksler; T A Sanborn; G Bergman; H L Bush
Journal:  J Clin Invest       Date:  1997-11-01       Impact factor: 14.808

5.  Decreased type II/type I TGF-beta receptor ratio in cells derived from human atherosclerotic lesions. Conversion from an antiproliferative to profibrotic response to TGF-beta1.

Authors:  T A McCaffrey; S Consigli; B Du; D J Falcone; T A Sanborn; A M Spokojny; H L Bush
Journal:  J Clin Invest       Date:  1995-12       Impact factor: 14.808

Review 6.  Cell biology of human vascular smooth muscle.

Authors:  P Chan
Journal:  Ann R Coll Surg Engl       Date:  1994-09       Impact factor: 1.891

7.  Growth inhibition of bovine pulmonary artery smooth muscle cells following long-term heparin treatment.

Authors:  Hicham Mrabat; Hari G Garg; Charles A Hales
Journal:  J Cell Physiol       Date:  2009-12       Impact factor: 6.384

8.  Proliferative capacity of vein graft smooth muscle cells and fibroblasts in vitro correlates with graft stenosis.

Authors:  Richard D Kenagy; Nozomi Fukai; Seung-Kee Min; Florencia Jalikis; Ted R Kohler; Alexander W Clowes
Journal:  J Vasc Surg       Date:  2009-05       Impact factor: 4.268

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.